GSK Settles 1st Avandia Suit Slated For Trial

Law360, New York (June 1, 2010, 5:15 PM EDT) -- GlaxoSmithKline PLC has settled the first suit set for trial in widespread litigation accusing the drugmaker of concealing the risks associated with its prescription diabetes medication Avandia.

A GSK spokeswoman said the company had reached a confidential settlement in a Philadelphia state court suit over Avandia that was scheduled to begin trial Tuesday and that no other pending state or federal court product liability cases were expected to start their trials until October.

The drugmaker is facing thousands of suits over its alleged failure to warn...
To view the full article, register now.